Novel approaches in the treatment of allergic rhinitis

Purpose of review - The increasing prevalence of allergic rhinitis, its impact on individual quality of life and social costs, as well as its role as a risk factor for asthma, underline the need for improved treatment options for this disorder. We reviewed the recent literature published in English...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schultz, Armin (VerfasserIn) , Stuck, Boris (VerfasserIn) , Feuring, Martin (VerfasserIn) , Hörmann, Karl (VerfasserIn) , Wehling, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [February 2003]
In: Current opinion in allergy and clinical immunology
Year: 2003, Jahrgang: 3, Heft: 1, Pages: 21-27
ISSN:1473-6322
DOI:10.1097/00130832-200302000-00004
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/00130832-200302000-00004
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/co-allergy/Fulltext/2003/02000/Novel_approaches_in_the_treatment_of_allergic.4.aspx
Volltext
Verfasserangaben:Armin Schultz, Boris Alexander Stuck, Martin Feuring, Karl Hörmann and Martin Wehling
Beschreibung
Zusammenfassung:Purpose of review - The increasing prevalence of allergic rhinitis, its impact on individual quality of life and social costs, as well as its role as a risk factor for asthma, underline the need for improved treatment options for this disorder. We reviewed the recent literature published in English, dealing with relevant and appropriately controlled clinical trials on the treatment of allergic rhinitis. - Recent findings - In addition to well established pharmacological therapies with antihistamines, corticosteroids, decongestants and mast cell stabilizers, new therapeutic options become increasingly important, including leukotriene modifiers, anti-immunoglobulin E antibodies, phosphodiesterase inhibitors and intranasal heparin; there also exist new developments in appropriate allergen specific immunotherapy. - Summary - Promising results, both with established and novel treatment options, are communicated, but further studies are still necessary to confirm these data.
Beschreibung:Gesehen am 27.04.2022
Beschreibung:Online Resource
ISSN:1473-6322
DOI:10.1097/00130832-200302000-00004